Author: Maureen Martino
Source: http://www.fiercevaccines.com
Interest: With the help of a four-year, $3 million grant from the National Institute of Allergy and Infectious Diseases, Inviragen and the University of Texas Medical Branch (UTMB) are furthering development of a preclinical vaccine for chikungunya virus.
Link: http://www.fiercevaccines.com/story/inviragen-u-texas-land-3m-grant-chikungunya-vaccine/2011-08-17
Loading...